G
Grey Matter Neurosciences
Portable focused ultrasound for non-invasive neuromodulation
About Grey Matter Neurosciences
Grey Matter Neurosciences is a Toronto-based neurotechnology company developing medical devices to treat age-related brain diseases like dementia. Founded in 2024 by neuroscientist and entrepreneur Dr. Jeffrey Coull, the company is commercializing transcranial focused ultrasound (FUS) technology licensed from the Sunnybrook Research Institute. This technology was invented by focused ultrasound pioneer Dr. Kullervo Hynynen and his team.
The company's core product is a portable ultrasound helmet designed to restore brain function in seniors. This non-invasive neuromodulation system uses low-power sound waves that converge to target structures deep within the brain, altering neural pathways to improve functions like memory and concentration. A key feature of the technology is its ability to operate without real-time image guidance (like an MRI) or patient immobilization, making it suitable for use in clinics and potentially at home.
Grey Matter Neurosciences secured $14 million in a seed financing round led by Wittington Innovation Fund, with participation from Toronto Innovation Acceleration Partners, the Ontario Centre of Innovation, and the Ontario Brain Institute. These funds are allocated for product development, advanced research, and to establish the safety and feasibility of the technology in a clinical trial for patients with Alzheimer's disease. The company plans to pursue drug-device combination products in the future, using its FUS platform for precise drug delivery to the brain.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 24
- Open positions
- None listed
- Dealroom signal
- 84.5/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Medical Research, Neurology, Alzheimers Disease, Spinout, elderly care, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Jan 2025 | $14M | $56M | Ontario Brain Institute · Wittington Ventures · Ontario Centre of Innovation | ↗ |
| SPINOUT✓Other financing | Dec 2024 | $0 | — | Sunnybrook Research Institute | — |
Growth signals
Latest recorded traffic for Grey Matter Neurosciences is 4.3K monthly website visits, up 258.3% over the last three months. Grey Matter Neurosciences's team grew 20% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Grey Matter Neurosciences in the Toronto ecosystem
The Grey Matter Neurosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Wittington Ventures
Ontario Brain Institute
Ontario Centre of Innovation
Other known investors2 additional known investors
Rogers Cybersecure Catalyst
Sunnybrook Research Institute
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Grey Matter Neurosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Grey Matter Neurosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








